Switch to:
More From Other Websites
Pfizer's Leukemia Candidate Gets Priority Review in U.S. Feb 22 2017
Pfizer Inc. (PFE) Invest For Attractive Valuation And The 4% Dividend Yield Feb 22 2017
Manufacturing Delay Of Generic Drug From Pfizer Inc. (PFE) A Relief For Teva Pharmaceutical... Feb 22 2017
Goldman Says Buy Health-Care, Retail Volatility Before Trump Address Feb 22 2017
Why Spark's CEO says 2017 may be a 'historic year' for his gene therapy company Feb 22 2017
Merck & Co.’s Segment-Wise Revenues for 4Q16 Feb 22 2017
World's Biggest Drugmaker Quits London and Swiss Listings Feb 22 2017
Early movers: TOL, DISH, SIX, TRCO, FSLR, & more Feb 22 2017
Viagra maker Pfizer cites poor performance for stock de-listing Feb 22 2017
Pfizer Quits London and Swiss Listings, Says 'Limited Liquidity' in European Trading Feb 22 2017
Momenta, Pfizer Give Teva Pharma Breathing Room On Generic MS Drug Feb 21 2017
Here’s What The Latest Pain Therapeutics, Inc. (PTIE) Update Means Feb 21 2017
Boeing, GE and Oracle CEOs Support Border Adjustment Tax in Letter to Congress Feb 21 2017
Execs from Boeing, Pfizer Send Letter Backing House GOP Tax Plan Feb 21 2017
8:02 am Pfizer announces that a BLA for inotuzumab ozogamicin has been accepted for filing and... Feb 21 2017
Pfizer Announces Acceptance of Regulatory Submission for Inotuzumab Ozogamicin by the U.S. Food and... Feb 21 2017


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK